LivaNova (LIVN) Tax Provisions (2014 - 2026)
LivaNova (LIVN) reported Tax Provisions of $4.3 million for Q1 2026, down 62.77% on a YoY basis from $11.7 million in Q1 2025, and up 232.24% sequentially from -$3.3 million in Q4 2025.
LivaNova (LIVN) Tax Provisions (2014 - 2026) Analysis & Trends
LivaNova (LIVN) has 13 years of Tax Provisions data on file, last reported at $4.3 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 62.77% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $14.3 million (down 50.61% YoY), and the FY2025 full-year result was $21.6 million, down 13.64% from the prior year.
- Tax Provisions grew to $4.3 million in Q1 2026, from -$3.3 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $11.7 million in Q1 2025 to a low of -$110.7 million in Q4 2023.
- A 5-year average of -$2.2 million and a median of $4.3 million in 2026 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 309.88% in 2023, while the deepest fall reached 2452.3% in 2023.
- Tracing LIVN's Tax Provisions over 5 years: stood at $4.7 million in 2022, then tumbled by 2452.3% to -$110.7 million in 2023, then soared by 100.53% to $589000.0 in 2024, then sank by 657.22% to -$3.3 million in 2025, then surged by 232.24% to $4.3 million in 2026.
- Business Quant data shows LIVN's Tax Provisions at $4.3 million in Q1 2026, -$3.3 million in Q4 2025, and $7.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 70.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 94.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 4.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.34 Mn |
| Dec 31, 2025 | -3.28 Mn |
| Sep 30, 2025 | 7.11 Mn |
| Jun 30, 2025 | 6.15 Mn |
| Mar 31, 2025 | 11.66 Mn |
| Dec 31, 2024 | 589,000.00 |
| Sep 30, 2024 | 11.53 Mn |
| Jun 30, 2024 | 5.23 Mn |
| Mar 31, 2024 | 7.72 Mn |
| Dec 31, 2023 | -110.65 Mn |
| Sep 30, 2023 | 5.31 Mn |
| Jun 30, 2023 | 4.10 Mn |
| Mar 31, 2023 | 2.37 Mn |
| Dec 31, 2022 | 4.70 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 2.54 Mn |
| Dec 31, 2021 | 2.79 Mn |
| Sep 30, 2021 | 1.86 Mn |
| Jun 30, 2021 | 3.91 Mn |